Apellis Pharmaceuticals Inc

NASDAQ:APLS  
42.65
+0.70 (+1.67%)
4:10:24 PM EDT: $43.22 +0.57 (+1.34%)
Earnings Announcements

Apellis Pharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/04/2022 21:54 GMT
Apellis Pharmaceuticals Inc (APLS) - Apellis Pharmaceuticals Reports First Quarter 2022 Financial Results.
Apellis Pharmaceuticals Inc - Total Revenue Was $14.4 Million for Q1 of 2022.
Revenue is expected to be $21.86 Million
Adjusted EPS is expected to be -$1.29

Next Quarter Revenue Guidance is expected to be $21.62 Million
Next Quarter EPS Guidance is expected to be -$1.35

More details on our Analysts Page.